About Ocugen

Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to treat blindness diseases aswell as co-developing and manufacturing various vaccines. Ocugen’s Covaxin Covid-19 vaccine co-development partner, Bharat Biotech, shares phase 3, second interim results demonstrating 100% protection against severe disease including hospitalization and overall clinical efficacy of 78%. Covaxin is already given to millions of people in India and around the world.